In this first part of a three-part webinar series, attendees had the opportunity to hear from clinical trial attorneys as they shared the critical pieces of a clinical trial agreement and how to mitigate risk. Attendees gained a better understanding of the requirements of both sponsors and sites and participate in a discussion about how to meet the needs of all parties in the contract.
This webinar focused on improving diversity in clinical trials through practical strategies for engaging underrepresented populations.
This webinar showed attendees that simply conducting background checks and employment verifications won’t always protect from candidates who represent a fake job history.
Did you read the new draft Guidance from the FDA for Sponsors, Investigators, and IRBs on Key Information and Facilitating Informed Consent? Watch this webinar as our speaker discusses this guidance.
Artificial intelligence (AI) has been touted as holding the solutions to a variety of vexing challenges in healthcare, but is it possible that there’s a downside to integrating what some might call an ungovernable technology into the clinical research arena? This webinar pondered the issue of who’s making sure this power is being used to benefit everyone fairly.